SE8400788D0 - Novel adenosine receptor antagonists - Google Patents
Novel adenosine receptor antagonistsInfo
- Publication number
- SE8400788D0 SE8400788D0 SE8400788A SE8400788A SE8400788D0 SE 8400788 D0 SE8400788 D0 SE 8400788D0 SE 8400788 A SE8400788 A SE 8400788A SE 8400788 A SE8400788 A SE 8400788A SE 8400788 D0 SE8400788 D0 SE 8400788D0
- Authority
- SE
- Sweden
- Prior art keywords
- receptor antagonists
- adenosine receptor
- novel adenosine
- novel
- phenylxanthines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/467,894 US4593095A (en) | 1983-02-18 | 1983-02-18 | Xanthine derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8400788D0 true SE8400788D0 (sv) | 1984-02-14 |
SE8400788L SE8400788L (sv) | 1984-08-19 |
SE456680B SE456680B (sv) | 1988-10-24 |
Family
ID=23857582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8400788A SE456680B (sv) | 1983-02-18 | 1984-02-14 | Derivat av 8-fenylxantin |
Country Status (10)
Country | Link |
---|---|
US (1) | US4593095A (sv) |
JP (1) | JPS59205377A (sv) |
BE (1) | BE898946A (sv) |
CA (1) | CA1234804A (sv) |
DE (1) | DE3406275A1 (sv) |
FR (1) | FR2541281B1 (sv) |
GB (2) | GB8403574D0 (sv) |
IT (1) | IT1196031B (sv) |
NL (1) | NL8400514A (sv) |
SE (1) | SE456680B (sv) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769377A (en) * | 1983-02-18 | 1988-09-06 | The Johns Hopkins University | Adenosine receptor antagonists |
US4696932A (en) * | 1984-10-26 | 1987-09-29 | The United States Of America As Represented By The Department Of Health And Human Services | Biologically-active xanthine derivatives |
GB8510758D0 (en) * | 1985-04-27 | 1985-06-05 | Wellcome Found | Compounds |
US5017577A (en) * | 1986-04-25 | 1991-05-21 | Burroughs Wellcome Co. | Methods for treating viral infection |
US4772607A (en) * | 1986-05-20 | 1988-09-20 | Warner-Lambert Company | Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
US4755517A (en) * | 1986-07-31 | 1988-07-05 | Warner-Lambert Company | Derivatives of xanthine, pharmaceutical compositions and methods of use therefor |
JPS63154687A (ja) * | 1986-11-13 | 1988-06-27 | マリオン・ラボラトリーズ・インコーポレーテッド | 8ーアリールキサンチン |
US4783530A (en) * | 1986-11-13 | 1988-11-08 | Marion Laboratories, Inc. | 8-arylxanthines |
US5015647A (en) * | 1987-04-24 | 1991-05-14 | Burroughs Wellcome Co. | Method for treating viral infections |
US5032593A (en) * | 1988-07-01 | 1991-07-16 | Marion Merrell Dow Inc. | Method of treating bronchoconstriction with 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines |
US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
DE8817122U1 (sv) * | 1988-12-22 | 1993-02-04 | Boehringer Ingelheim Kg, 6507 Ingelheim, De | |
GB8906792D0 (en) * | 1989-03-23 | 1989-05-10 | Beecham Wuelfing Gmbh & Co Kg | Treatment and compounds |
US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
IL100088A (en) * | 1990-11-21 | 1995-07-31 | Smithkline Beecham Corp | FNT inhibitor preparations containing histogenic transducts converted at positions 1, 3, and 8 |
US5484920A (en) * | 1992-04-08 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for Parkinson's disease |
TW252044B (sv) * | 1992-08-10 | 1995-07-21 | Boehringer Ingelheim Kg | |
JP2613355B2 (ja) * | 1992-09-28 | 1997-05-28 | 協和醗酵工業株式会社 | パーキンソン氏病治療剤 |
US5877179A (en) * | 1992-09-29 | 1999-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Xanthines for identifying CFTR--binding compounds useful for activating chloride conductance in animal cells |
AU6781194A (en) * | 1993-05-03 | 1994-11-21 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
US5504090A (en) * | 1994-03-30 | 1996-04-02 | Trustees Of The University Of Pennsylvania | Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury |
GB9415529D0 (en) * | 1994-08-01 | 1994-09-21 | Wellcome Found | Phenyl xanthine derivatives |
US6323201B1 (en) | 1994-12-29 | 2001-11-27 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
US6930101B1 (en) * | 1999-05-17 | 2005-08-16 | The Regents Of The University Of California | Thiazolopyrimidines useful as TNFα inhibitors |
US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
ES2166270B1 (es) * | 1999-07-27 | 2003-04-01 | Almirall Prodesfarma Sa | Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona. |
US6815446B1 (en) | 1999-08-31 | 2004-11-09 | Vanderbilt University | Selective antagonists of A2B adenosine receptors |
ATE319452T1 (de) * | 1999-10-29 | 2006-03-15 | Kyowa Hakko Kogyo Kk | Arzneimittel gegen essstörungen |
CA2439222C (en) * | 2000-02-23 | 2009-07-14 | Cv Therapeutics, Inc. | Identification of partial agonists of the a2a adenosine receptor |
US20080318983A1 (en) * | 2001-11-09 | 2008-12-25 | Rao Kalla | A2b adenosine receptor antagonists |
US7317017B2 (en) | 2002-11-08 | 2008-01-08 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US7125993B2 (en) * | 2001-11-09 | 2006-10-24 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US6977300B2 (en) * | 2001-11-09 | 2005-12-20 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
MXPA04004388A (es) | 2001-11-09 | 2005-05-16 | Cv Therapeutics Inc | Antagonistas del receptor a2b de adenosina. |
NZ528591A (en) * | 2002-02-01 | 2006-11-30 | King Pharmaceuticals Res & Dev | 8-heteroaryl xanthine adenosine A2B receptor antagonists and their pharmaceutical use |
US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
US20050020915A1 (en) * | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
NZ537975A (en) * | 2002-07-29 | 2007-08-31 | Cv Therapeutics Inc | Method of producing coronary vasodilation without peripheral vasodilation comprising administering at least 10 mcg of at least one A2A receptor agonist |
PT1789053E (pt) * | 2004-09-01 | 2012-08-09 | Gilead Sciences Inc | Método de cicatrização de feridas utilizando antagonistas dos receptores de adenosina a2b |
JP2008517063A (ja) | 2004-10-20 | 2008-05-22 | シーブイ・セラピューティクス・インコーポレイテッド | A2aアデノシンレセプターアゴニストの使用 |
WO2007092372A1 (en) * | 2006-02-03 | 2007-08-16 | Cv Therapeutics, Inc. | Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
KR20090047499A (ko) * | 2006-09-01 | 2009-05-12 | 씨브이 쎄러퓨틱스, 인코포레이티드 | 심근 조영법 동안에 환자의 순응성을 증가시키기 위한 방법및 조성물 |
CA2663361A1 (en) * | 2006-09-29 | 2008-04-10 | Cv Therapeutics, Inc. | Methods for myocardial imaging in patients having a history of pulmonary disease |
MX2009007071A (es) * | 2007-01-03 | 2009-10-13 | Cv Therapeutics Inc | Elaboracion de imagen de perfusion del miocardio. |
JP2012504147A (ja) * | 2008-09-29 | 2012-02-16 | ギリアード サイエンシーズ, インコーポレイテッド | 多検出器型コンピュータ断層撮影法において使用するための心拍数コントロール薬およびA−2−α受容体作動薬の組み合わせ |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2840559A (en) * | 1954-06-22 | 1958-06-24 | Krantz Jr | Nuclearly substituted 8-theophyllines and method of making the same |
DE1091570B (de) * | 1958-10-23 | 1960-10-27 | Albert Ag Chem Werke | Verfahren zur Herstellung von in 8-Stellung substituierten 1, 3-Dialkylxanthinen |
GB982079A (en) * | 1962-05-01 | 1965-02-03 | Dresden Arzneimittel | Process for the production of xanthine derivatives |
BE636699A (sv) * | 1962-08-31 | |||
EP0011399A1 (en) * | 1978-11-11 | 1980-05-28 | FISONS plc | N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them |
US4452788A (en) * | 1982-04-21 | 1984-06-05 | Warner-Lambert Company | Substituted 8-phenylxanthines |
-
1983
- 1983-02-18 US US06/467,894 patent/US4593095A/en not_active Expired - Fee Related
-
1984
- 1984-02-10 GB GB848403574A patent/GB8403574D0/en active Pending
- 1984-02-14 SE SE8400788A patent/SE456680B/sv not_active IP Right Cessation
- 1984-02-17 FR FR8402472A patent/FR2541281B1/fr not_active Expired
- 1984-02-17 DE DE19843406275 patent/DE3406275A1/de not_active Ceased
- 1984-02-17 NL NL8400514A patent/NL8400514A/nl not_active Application Discontinuation
- 1984-02-17 BE BE0/212418A patent/BE898946A/fr not_active IP Right Cessation
- 1984-02-17 GB GB08404243A patent/GB2135311B/en not_active Expired
- 1984-02-17 CA CA000447705A patent/CA1234804A/en not_active Expired
- 1984-02-17 IT IT19675/84A patent/IT1196031B/it active
- 1984-02-18 JP JP59028010A patent/JPS59205377A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US4593095A (en) | 1986-06-03 |
BE898946A (fr) | 1984-06-18 |
GB8403574D0 (en) | 1984-03-14 |
GB2135311B (en) | 1986-11-05 |
CA1234804A (en) | 1988-04-05 |
GB8404243D0 (en) | 1984-03-21 |
GB2135311A (en) | 1984-08-30 |
FR2541281B1 (fr) | 1988-01-29 |
SE8400788L (sv) | 1984-08-19 |
IT1196031B (it) | 1988-11-10 |
FR2541281A1 (fr) | 1984-08-24 |
IT8419675A0 (it) | 1984-02-17 |
JPS59205377A (ja) | 1984-11-20 |
SE456680B (sv) | 1988-10-24 |
NL8400514A (nl) | 1984-09-17 |
DE3406275A1 (de) | 1984-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8400788D0 (sv) | Novel adenosine receptor antagonists | |
ATE30023T1 (de) | Leukotrien-antagonisten. | |
NO851516L (no) | Krysstang-kvadrupolkilde for akustisk broennlogging. | |
ES516374A0 (es) | Procedimiento para la obtencion de composiciones poliolefinicas. | |
NO831341L (no) | Laarbenkomponent for hofteleddprotese. | |
DK567884A (da) | (bicyklisk heterocyclyl)holdige n-(bicyklisk heterocyclyl)-4-piperidinamider | |
FI842211A0 (fi) | Kefalosporin derivat. | |
FI841505A (fi) | Substituerade indeno-pyridazioner. | |
NO162353C (no) | Lengderegulerbart boreroerstykke. | |
DE3482685D1 (de) | Leukotrien-antagonisten. | |
FI840101A0 (fi) | Ledanordning foer skjutvapen | |
ES540009A0 (es) | Procedimiento de obtencion de polipeptidos | |
ES527234A0 (es) | Procedimiento para la obtencion de 2-aril-4,6-dihalogenopirimidinas | |
FI841008A (fi) | 7-oxabicykloheptansubstituerade prostaglandinanaloger. | |
IT8467449A1 (it) | Procedimento per ottenere vetro piano ricoperto. | |
IT1179797B (it) | Tornio per lavorazioni composite | |
ES523724A0 (es) | Procedimiento de obtencion de fosfinamidas con efectos antitumorales. | |
ES536488A0 (es) | Procedimiento de obtencion de 6-metil-19-nor-pregna 4, 6 dieno 3, 20-dionas | |
FR2555587B1 (fr) | Derives de 14-des(hydroxymethyl)-mycaminosyltylonolide | |
AR240451A1 (es) | Procedimiento para la obtenicon de pirrolidinonas. | |
FI830081A0 (fi) | 6-aminoalkylpenicillansyra-1,1-dioxider och deras derivat som -laktamas-inhibitorer | |
DE69012388T2 (de) | Selektive Adenosinrezeptor-Verbindungen. | |
DE69004455T2 (de) | Alpha-adrenergene Rezeptor-Antagonisten. | |
IT8422749A0 (it) | Derivati di as-triazine condensati. | |
MX9203754A (es) | Antagonistas de leucotrieno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8400788-9 Effective date: 19940910 Format of ref document f/p: F |